Dashboards/Oversight
Risk Levelling
Ongoing Site Risk Leveling
Source Data Review and Source Data Verification
Miscellanous
100

Name one tool/system CLMs should use to keep country oversight 

IRIS CDA and RAVEN

RAVE, vendor reports, IMPACT, CART, Gemstone Veeva Vault Clinical

100

Where can you find the study risk level for your study?

Study Site Monitoring Plan 

or 

IRIS CDA, study risk leveling dashboard

Gemstone Veeva Vault Clinical Study Additional Details 

100

True or False

As a CLM, I determine the OsRL?

FALSE

This is calculated within IRIS OMVR/OsRL tab by the CRA

100

True or False

SDR = Transcription check between source and eCRF  
SDV = Review of subject source to ensure site compliance to GCP and protocol

False

It is the opposite


100

True or False

It is recommended that a CRA discusses potential risk level override for one of their sites with you

True


200

How do I get access to RAVEN?

Complete RAVEN overview training in My Learning, complete a PRIMA4PWP request with studies you need access to


200

True or False:

The CLM is responsible for determining the study risk level for their country

False

This is determined by the study team

200

How do I compare the Site Risk of my country's sites against the other sites in the study?

In the RAVEN OsRL dashboard and in IRIS CDA (OsRL dashboard report)

200

Where are SDR AND SDV documented?

SDR: SDR tab in IRIS OMVR

SDV in RAVE

200

Which question must be answered within the IRIS report before an OSRL can be calculated?

And - how long does it take for data to be pulled to the ongoing site risk leveling in IRIS?

The question related to PI oversight & you should allow 1 day from the visit end date completed in IRIS


300

Name the tool to be used to determine which subjects the CRA will SDR at each monitoring event?

The Workload Forecasting Tool in RAVEN

300

Where is the site monitoring intervention table showing max intervals and percentage of SDR/SDV to be completed?

In the study site monitoring plan


300

Name 2 of the benefits you get by reviewing the site risk indicators on a regular basis, instead of only at the time of ongoing site risk leveling.

Notice trends.

Follow up with CRA in a timely manner

Notice issues before they become severe

Become aware of your country and sites' status performance

Reviewing data that can support decision-making

Discover what to focus on

300

Where can I find what is considered critical data for my study?


Integrated Data Review Plan (IDRP)


300

If I have an RBQM/RAVEN question, where do I go? Provide at least 2 answers

RBQM SharePoint

RAVEN SharePoint

RBQM Manual

RAVEN RBQM Guidance 

Use the RBQM support email (rbqm@bayer.com)

Contact my RBM Leader, RAVEN super user

RAVEN Open Clinics

400

Which risk indicator in RAVEN can you look at for the distribution of AEs in your country and to see trends as well as how individual sites compare to other sites within the study?

AE & SAE Incidence Indicator (in the OsRL Dashboard) in RAVEN

400

Can the study risk level change throughout the study life cycle? YES or NO? Provide rationale

Yes, it can but it's rare. 

Usually, once the SRL is determined by the study team it will remain throughout the study. However, the study team may reassess SRL due to a protocol amendment, a change in study design.  If there is a change, the monitoring plan will need to be updated as well.  

400

Provide 2 examples of valid reasons you would see an override?

Multiple GCP violations, trending deviations/issues, site not following basic standards of conducting clinical research (ICH GCP), etc.

400

What determines the amount of SDV/SDR at a site?

Study and Site Risk Level and number of randomized subjects

400

True or False
The ongoing site risk level can only go one risk level up or down

False 

The ongoing site risk level is not related to the previous risk level, it is independently calculated.  

500

In what RAVEN dashboard can I review the number of important deviations and validity findings, assess any missing information and also review trends compared to other countries & study.

RAVEN COD Quality - DFF2

Clinical Overview Dashboard Quality - Deviations & Findings Frequency

500

How is the study risk level assessed?

A set of questions/risk statements based on the Transcelerate RACT  (Risk Assessment and Categorization Tool)

(Refer to IRIS SP site-SRL guidance document)

500

Name at least three of your responsibilities as a CLM in reviewing the ongoing site risk leveling per site?

Review the OsRL in each monitoring event 

Ensure proposed actions by the CRA are appropriate and effective per the risk level (yellow/red). Note that every red indicator does require a comment by the CRA

Review if override occurred and the override reason is selected and valid

Are FUIs or PDs documented as needed in IRIS

Review the OsRL in RAVEN for oversight for trends.

Over time, indicators should improve. If it doesn’t, is additional action needed? 

500

Your CRA is concerned about not looking at all the data in the eCRF. Name at least 3 other functional reviews of data that are performed, besides the CRA's review.

Edit checks, DM review, ME review, CDR, PV review (SAE data)

500

Name two roles that perform central data review.

Data Manager, Statistician, Central Data Reviewer, core study team

M
e
n
u